Abstract

The coronavirus disease (COVID-19) pandemic has resulted in remarkable progress in understanding the disease through research and innovation at a pace far faster than possible pre-2020. For clinical trials, a key challenge has been the trade-off between “quick” answers versus those that have a longer time horizon and require more data collection. Understanding the implications of these approaches is critical when the aim is measuring sustained patient recovery.

Rights

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/

Cite as

Griffith, D. & Walsh, T. 2022, 'Outcomes from COVID-19 Clinical Trials in Hospitalized Patients: Seeking the Truth That Matters', American Journal of Respiratory and Critical Care Medicine, 206(6), pp. 659-660. https://doi.org/10.1164/rccm.202205-0907ED

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 01 August 2023
Was this page helpful?